A federal appeals court in Washington approves Myriad's patents on breast-cancer genes, setting up another fight with the Supreme Court.
Daniel Fisher, Forbes
Thu, 08/16/2012 - 11:23am
A federal appeals court in Washington approves Myriad's patents on breast-cancer genes, setting up another fight with the Supreme Court.